A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

NCT06895928 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-A2102
DRUG: Bevacizumab Injection
DRUG: Adebelimab Injection
DRUG: Ametinib Mesylate Tablets
DRUG: Osimertinib Mesylate Tablets

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.